NGFN Facts and Figure
4. Patents from NGFN-1, NGFN-2, NGFN-Plus and NGFN-Transfer
Taking the fast lane from research to utilization
The utilization of research results from NGFN-Plus and NGFN-Transfer is an important aim of the Program of Medical Genome Research. A crucial step for the practical application is the filing of patents for protectable inventions and developments. Therefore the number of patents is a measure for the practical returns of NGFN research.
The diagram shows the number of patents granted in the respective funding periods of NGFN. For the current reporting period all 19 filed patents were counted.
Patent number: EP10001596.5
Title: Means and methods for diagnosing pancreatic cancer
Inventor: Christoph Schröder, Jörg Hoheisel, Crnogorac Jurcevic; Applicant: DKFZ;
Priority date: 17.10.2010; State: Pending
Patent number: EP09006620.0
Title: Methods for the Diagnosis and the Prognosis of a Brain Tumor
Inventor: von Deimling, Hartmann, Zentgraf, Reifenberger, Capper, Weller, Wick
Applicant: Deutsches Krebsforschungszentrum, Ruprecht-Karls-Universität
Heidelberg; Priority date: 15.05.2009; State: Pending
Patent number: EP 10004898
Title: Risk prognosis method for chronic lymphocytic leukemia
Inventor: Herold, Jurinovic, Buske, Bohlander; Applicant: Ludwig-Maximilians-
Universität München; Priority date: 07.05.2010; State: Pending
Patent number: EP 09 158 709.7
Title: Use of MLKL in cancer therapy
Inventor: Mollenhauer, Hudler, Blaich, Wittig; Applicant: Deutsches
Krebsforschungszentrum; Priority date: 24.04.2009; State: Pending
Patent number: 10 2010 024 512.7
Title: Neue Ansätze für die Tumortherapie- Histondemethylasen
Inventor: PD Dr. Alexander SchrammDr. Johannes SchulteProf. Dr. Angelika Eggert;
Applicant: Universität Duisburg-Essen; Priority date: 21.06.2010; State: Pending
Patent number: EP09177117.0
Title: Pyrosequencing method for predicting the response of a patient towards anti
cancer treatment
Inventor: Altmüller, Nürnberg, Querings, Applicant: Altmüller;
Priority date: 25.11.2009; State: Pending
Patent number: EP10005512.9
Title: Development of fluorescently P-loop labeled kinases for screening of inhibitors
Inventor: RAUH, Daniel; SIMARD, Jeffrey; Applicant: MAX-PLANCK-GESELLSCHAFT
ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V., Hofgartenstr. 8, 80539 München;
Priority date: 17.04.2010; State: Pending
Patent number: EP09/005364; WO/2010/009886
Title: Fluorescently or spin-labeled kinases for rapid screening and identification of
novel kinase inhibitor scaffolds
Inventor: RAUH, Daniel; SIMARD, Jeffrey; GETLIK, Matthäus; Applicant: MAX-
PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.,
Hofgartenstr. 8 80539 München; Priority date: 17.04.2009; State: Pending
Patent number: 09 174 455.7
Title: Circulating miRNAs as non-invasive markers for diagnosis and staging in
prostate cancer
Inventor: Jan C. Brase, Marc Johannes, Thorsten Schlomm, Maria Fälth, Alexander
Haese, Thomas Steuber, Tim Beissbarth, Ruprecht Kuner, Holger Sültmann;
Applicant: DKFZ; Priority date: 29.10.2009; State: Pending
Patent number: DE202009008601U
Title: Inkubationsschale für Proteinarray-Inkubationen (Gebrauchsmuster)
Inventor: DKFZ Heidelberg, Metecon Mannheim; Applicant: DKFZ;
Priority date: 19.06.2009; State: Published
Patent number: EP08162056.9
Title: "Mutant alpha-synuclein, and methods using same"
Inventor: Markus Zweckstetter, Damla Pinar Karpinar, Christian Griesinger;
Applicant: Max-Planck-Gesellschaft; Priority date: 08.08.2008; State: Pending
Patent number: EP09014709.1 und EP 09014889 US61/264,514 und US 61/265,296
Title: Conditional expression of transgenes in vivo
Inventor: Laura Schebelle, Frank Schnütgen, Thomas Floss; Applicant: Helmholtz
Zentrum München; Priority date: 01.11.2009; State: Pending
Patent number: US 61/255,621
Title: Homologous recombination in the oocyte
Inventor: Ralf Kühn, Melanie Meyer, Wolfgang Wurst
Applicant: Ralf Kühn, Melanie Meyer, Wolfgang Wurst; Helmholtz Zentrum München;
Priority date: 28.10.2009; State: Pending
Patent number: EP09006623.4-2403
Title: X-chromosomal variation as a diagnostic and therapeutic marker for the
progression to AIDS
Inventor: Siddiqui, Roman; Sauermann, Ulrike; Altmüller, Janine; Nürnberg, Peter;
Fritzer, Elfriede; Nothnagel, Michael; Krawczak, Michael; Platzer, Mathias;
Applicant: Deutsches Primatenzentrum GmbH, et al.; Priority date: 11.11.2008;
State: Pending
Patent number: PCT/EP2009/007793
Title: Use of inhibitors of host kinases for the treatment of infectious diseases
Inventor: Hannus et al.; Applicant: Cenix BioScience GmbH;
Priority date: 31.10.2008; State: Pending
Patent number: Exploitation without patent
Title: Genomwide RNAi Screen for host specific factors in liver form of
malaria infections
Patent number: 20090325170
Title: Means and methods for diagnosing heart failure in a subject
Inventor: Prof. Dr. med. H. A. Katus, Prof. Dr. med. N. Frey, Dr. med. T. Weis,
Johanna Wolf; Applicant: Metanomics Health and University Heidelberg;
Priority date: 29.01.2010; State: Pending
Patent number: EP09171773.6 BHC 09 1041
Title: Angioprotektin: A vasoprotective angiotensin-peptide as a potentiel
biomarker for diagnostic, prognostic und follow up of chronically renal insufficiency
Inventor: Prof. Dr. J. Jankowski, Dr. V. Jankowski, Prof. Dr. W. Zidek,
Dr. A. Kretschmer, Prof. Dr. R. Santos, Prof. Dr. M. van der Giet;
Applicant: Bayer-Schering; Priority date: 30.09.2009; State: Pending
Patent number: 2009P22915EP
Title: Method for breast cancer recurrence prediction under endocrine treatment
Inventor: Christian von Törne, Guido Hennig, Inke Sabine Feder, Karsten Weber,
Mareike Assink, Mathias Gehrmann; Applicant: Siemens AG;
Priority date: 31.3.2010; State: Pending
Patent number: DE102009024143.4
Title: Amplification of complex nucleic acids
Applicant: Qiagen GmbH, Korfhage and Fisch; Priority date: 04.06.2009;
State: Pending
Download this website as pdf
The utilization of research results from NGFN-Plus and NGFN-Transfer is an important aim of the Program of Medical Genome Research. A crucial step for the practical application is the filing of patents for protectable inventions and developments. Therefore the number of patents is a measure for the practical returns of NGFN research.
The diagram shows the number of patents granted in the respective funding periods of NGFN. For the current reporting period all 19 filed patents were counted.
Patents of NGFN-Plus und NGFN-Transfer
Patent number: EP10001596.5
Title: Means and methods for diagnosing pancreatic cancer
Inventor: Christoph Schröder, Jörg Hoheisel, Crnogorac Jurcevic; Applicant: DKFZ;
Priority date: 17.10.2010; State: Pending
Patent number: EP09006620.0
Title: Methods for the Diagnosis and the Prognosis of a Brain Tumor
Inventor: von Deimling, Hartmann, Zentgraf, Reifenberger, Capper, Weller, Wick
Applicant: Deutsches Krebsforschungszentrum, Ruprecht-Karls-Universität
Heidelberg; Priority date: 15.05.2009; State: Pending
Patent number: EP 10004898
Title: Risk prognosis method for chronic lymphocytic leukemia
Inventor: Herold, Jurinovic, Buske, Bohlander; Applicant: Ludwig-Maximilians-
Universität München; Priority date: 07.05.2010; State: Pending
Patent number: EP 09 158 709.7
Title: Use of MLKL in cancer therapy
Inventor: Mollenhauer, Hudler, Blaich, Wittig; Applicant: Deutsches
Krebsforschungszentrum; Priority date: 24.04.2009; State: Pending
Patent number: 10 2010 024 512.7
Title: Neue Ansätze für die Tumortherapie- Histondemethylasen
Inventor: PD Dr. Alexander SchrammDr. Johannes SchulteProf. Dr. Angelika Eggert;
Applicant: Universität Duisburg-Essen; Priority date: 21.06.2010; State: Pending
Patent number: EP09177117.0
Title: Pyrosequencing method for predicting the response of a patient towards anti
cancer treatment
Inventor: Altmüller, Nürnberg, Querings, Applicant: Altmüller;
Priority date: 25.11.2009; State: Pending
Patent number: EP10005512.9
Title: Development of fluorescently P-loop labeled kinases for screening of inhibitors
Inventor: RAUH, Daniel; SIMARD, Jeffrey; Applicant: MAX-PLANCK-GESELLSCHAFT
ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V., Hofgartenstr. 8, 80539 München;
Priority date: 17.04.2010; State: Pending
Patent number: EP09/005364; WO/2010/009886
Title: Fluorescently or spin-labeled kinases for rapid screening and identification of
novel kinase inhibitor scaffolds
Inventor: RAUH, Daniel; SIMARD, Jeffrey; GETLIK, Matthäus; Applicant: MAX-
PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.,
Hofgartenstr. 8 80539 München; Priority date: 17.04.2009; State: Pending
Patent number: 09 174 455.7
Title: Circulating miRNAs as non-invasive markers for diagnosis and staging in
prostate cancer
Inventor: Jan C. Brase, Marc Johannes, Thorsten Schlomm, Maria Fälth, Alexander
Haese, Thomas Steuber, Tim Beissbarth, Ruprecht Kuner, Holger Sültmann;
Applicant: DKFZ; Priority date: 29.10.2009; State: Pending
Patent number: DE202009008601U
Title: Inkubationsschale für Proteinarray-Inkubationen (Gebrauchsmuster)
Inventor: DKFZ Heidelberg, Metecon Mannheim; Applicant: DKFZ;
Priority date: 19.06.2009; State: Published
Patent number: EP08162056.9
Title: "Mutant alpha-synuclein, and methods using same"
Inventor: Markus Zweckstetter, Damla Pinar Karpinar, Christian Griesinger;
Applicant: Max-Planck-Gesellschaft; Priority date: 08.08.2008; State: Pending
Patent number: EP09014709.1 und EP 09014889 US61/264,514 und US 61/265,296
Title: Conditional expression of transgenes in vivo
Inventor: Laura Schebelle, Frank Schnütgen, Thomas Floss; Applicant: Helmholtz
Zentrum München; Priority date: 01.11.2009; State: Pending
Patent number: US 61/255,621
Title: Homologous recombination in the oocyte
Inventor: Ralf Kühn, Melanie Meyer, Wolfgang Wurst
Applicant: Ralf Kühn, Melanie Meyer, Wolfgang Wurst; Helmholtz Zentrum München;
Priority date: 28.10.2009; State: Pending
Patent number: EP09006623.4-2403
Title: X-chromosomal variation as a diagnostic and therapeutic marker for the
progression to AIDS
Inventor: Siddiqui, Roman; Sauermann, Ulrike; Altmüller, Janine; Nürnberg, Peter;
Fritzer, Elfriede; Nothnagel, Michael; Krawczak, Michael; Platzer, Mathias;
Applicant: Deutsches Primatenzentrum GmbH, et al.; Priority date: 11.11.2008;
State: Pending
Patent number: PCT/EP2009/007793
Title: Use of inhibitors of host kinases for the treatment of infectious diseases
Inventor: Hannus et al.; Applicant: Cenix BioScience GmbH;
Priority date: 31.10.2008; State: Pending
Patent number: Exploitation without patent
Title: Genomwide RNAi Screen for host specific factors in liver form of
malaria infections
Patent number: 20090325170
Title: Means and methods for diagnosing heart failure in a subject
Inventor: Prof. Dr. med. H. A. Katus, Prof. Dr. med. N. Frey, Dr. med. T. Weis,
Johanna Wolf; Applicant: Metanomics Health and University Heidelberg;
Priority date: 29.01.2010; State: Pending
Patent number: EP09171773.6 BHC 09 1041
Title: Angioprotektin: A vasoprotective angiotensin-peptide as a potentiel
biomarker for diagnostic, prognostic und follow up of chronically renal insufficiency
Inventor: Prof. Dr. J. Jankowski, Dr. V. Jankowski, Prof. Dr. W. Zidek,
Dr. A. Kretschmer, Prof. Dr. R. Santos, Prof. Dr. M. van der Giet;
Applicant: Bayer-Schering; Priority date: 30.09.2009; State: Pending
Patent number: 2009P22915EP
Title: Method for breast cancer recurrence prediction under endocrine treatment
Inventor: Christian von Törne, Guido Hennig, Inke Sabine Feder, Karsten Weber,
Mareike Assink, Mathias Gehrmann; Applicant: Siemens AG;
Priority date: 31.3.2010; State: Pending
Patent number: DE102009024143.4
Title: Amplification of complex nucleic acids
Applicant: Qiagen GmbH, Korfhage and Fisch; Priority date: 04.06.2009;
State: Pending
Download this website as pdf
KTT
MEDIA
CURRENT
JOBS
NGFN- MEETING
NGFN1&2
LINKS